Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

about

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

Item

http://www.wikidata.org/entity/Q55456202

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

@en

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

@nl

type

Item

label

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

@en

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

@nl

prefLabel

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

@en

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

@nl

P1476

Genotyping performance evaluation of commercially available HIV-1 drug resistance test

@en

P2093

Agbaji Oche

http://www.w3.org/2001/XMLSchema#string

Ahmed Mukhtar

http://www.w3.org/2001/XMLSchema#string

Chaplin Beth

http://www.w3.org/2001/XMLSchema#string

Chebu Philippe

http://www.w3.org/2001/XMLSchema#string

Dalhatu Ibrahim

http://www.w3.org/2001/XMLSchema#string

DeVos Joshua

http://www.w3.org/2001/XMLSchema#string

Ezechi Oliver

http://www.w3.org/2001/XMLSchema#string

Idigbe Emmanuel

http://www.w3.org/2001/XMLSchema#string

Imade Godwin

http://www.w3.org/2001/XMLSchema#string

Kanki Phyllis

http://www.w3.org/2001/XMLSchema#string

P2860

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings

HIV-1 antiretroviral resistance: scientific principles and clinical applications

Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains.

Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa.

Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study.

Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resource-limited country

Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.

Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.

First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia

Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery.

P304

e0198246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0198246

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Audu Rosemary

P577

2018-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29953436

http://www.w3.org/2001/XMLSchema#string

P932

6023177

http://www.w3.org/2001/XMLSchema#string